Insider Selling: Alignment Healthcare (NASDAQ:ALHC) Insider Sells $269,575.70 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 32,479 shares of the company’s stock in a transaction that occurred on Tuesday, October 6th. The shares were sold at an average price of $8.30, for a total value of $269,575.70. Following the completion of the sale, the insider owned 299,271 shares in the company, valued at approximately $2,483,949.30. This represents a 9.79% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Alignment Healthcare Price Performance

Shares of NASDAQ:ALHC opened at $7.55 on Friday. Alignment Healthcare, Inc. has a twelve month low of $6.01 and a twelve month high of $25.12. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 1.22. The company has a market cap of $1.57 billion, a PE ratio of 39.74 and a beta of 1.14. The company’s 50 day moving average is $11.49 and its 200 day moving average is $16.63.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.13 by $0.04. The business had revenue of $1.34 billion during the quarter, compared to analysts’ expectations of $1.31 billion. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The business’s quarterly revenue was up 31.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.07 EPS. On average, sell-side analysts forecast that Alignment Healthcare, Inc. will post 0.17 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on ALHC shares. UBS Group reaffirmed a “neutral” rating on shares of Alignment Healthcare in a report on Wednesday, July 8th. Raymond James Financial lowered Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and lowered their price objective for the stock from $22.00 to $19.00 in a research report on Monday, August 3rd. Wall Street Zen lowered shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. William Blair cut shares of Alignment Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday. Finally, KeyCorp lowered their price target on shares of Alignment Healthcare from $28.00 to $12.00 and set an “overweight” rating on the stock in a report on Friday. Seven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $19.18.

Institutional Trading of Alignment Healthcare

Several institutional investors have recently bought and sold shares of ALHC. Wellington Management Group LLP raised its position in Alignment Healthcare by 9.8% during the second quarter. Wellington Management Group LLP now owns 18,780,363 shares of the company’s stock worth $447,160,000 after acquiring an additional 1,681,427 shares during the period. William Blair Investment Management LLC acquired a new stake in shares of Alignment Healthcare in the second quarter valued at about $184,799,000. Danica Pension Livsforsikringsaktieselskab acquired a new stake in shares of Alignment Healthcare in the second quarter valued at about $87,794,000. Bank of New York Mellon Corp purchased a new stake in shares of Alignment Healthcare during the second quarter worth about $87,077,000. Finally, Geode Capital Management LLC raised its position in shares of Alignment Healthcare by 8.4% during the 4th quarter. Geode Capital Management LLC now owns 3,841,703 shares of the company’s stock worth $75,884,000 after purchasing an additional 299,279 shares during the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare News Summary

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Six of Alignment Healthcare’s seven eligible Medicare Advantage contracts earned CMS 2027 ratings of 4 Stars or higher, including three plans rated 4.5 Stars. The contracts cover Arizona, California, Nevada, North Carolina and Texas. Alignment Healthcare Earns 4 Stars or Higher for Six of Seven Eligible Medicare Advantage Contracts
• Positive Sentiment: JPMorgan lowered its price target from $22 to $10 but maintained an “overweight” rating, while KeyCorp reduced its target from $28 to $12 and also kept an “overweight” rating. These targets imply substantial upside from recent levels. Analyst Comments on Alignment Healthcare
• Neutral Sentiment: A reported October short-interest figure showed zero shares short and a zero-day days-to-cover ratio. That data suggests short covering is not a significant explanation for the session’s trading, although the figure appears inconsistent with the report’s description of a “significant increase.”
• Negative Sentiment: Alignment’s California H3815 HMO contract received a 3.5-Star rating, below the 4-Star threshold that can affect Medicare Advantage enrollment appeal and quality-related payments. The company disputes the result and plans to pursue administrative and legal remedies, but investors are concerned about potential effects on membership, revenue and future bonuses. Alignment Healthcare Stock Falls on 2027 Medicare Star Ratings
• Negative Sentiment: William Blair downgraded the stock to “Market Perform,” adding to the pressure from sharply reduced price targets. The market’s reaction indicates that the weaker California rating is outweighing the company’s otherwise strong plan-rating performance. William Blair Downgrades Alignment Healthcare
• Negative Sentiment: Chief Medical Officer Hyong Kim sold 32,479 shares to cover tax withholding on vested equity awards. The transaction is relatively small and tax-related, but it adds to investor scrutiny after recent insider selling. Alignment Healthcare Insider Share Sale

About Alignment Healthcare

Alignment Healthcare, Inc is a technology-enabled Medicare Advantage company focused on providing health coverage and care services for older adults. The company offers Medicare Advantage plans that combine medical benefits with care coordination, wellness support, and other services designed to help members manage their health.

Alignment operates through an integrated healthcare model that uses its proprietary technology platform to support physicians, care teams, and members. Its services include personalized care management, clinical coordination, virtual and in-home support, and member assistance through its concierge-style approach.